Core Viewpoint - Tianchen Medical (688013) experienced a decline in stock price, closing at 56.0 yuan on November 14, 2025, with a drop of 2.12% [1] Group 1: Stock Performance and Trading Data - On November 14, 2025, the trading volume was 14,400 hands, with a total transaction amount of 81.39 million yuan [1] - The net inflow of main funds was 4.10 million yuan, accounting for 5.04% of the total transaction amount, while retail investors had a net outflow of 6.95 million yuan, representing 8.54% of the total [1] - Over the past five days, the stock price fluctuated, with a peak closing price of 57.21 yuan on November 13, 2025, and a low of 52.68 yuan on November 11, 2025 [2] Group 2: Financial Performance and Industry Comparison - For the first three quarters of 2025, Tianchen Medical reported a main revenue of 244 million yuan, a year-on-year increase of 20.66%, and a net profit of 71.95 million yuan, up 68.29% year-on-year [3] - The company's gross profit margin stands at 63.22%, significantly higher than the industry average of 51.22%, and its net profit margin is 29.51%, compared to the industry average of 9.57% [3] - Tianchen Medical's total market value is 4.545 billion yuan, with a net asset of 600 million yuan, and it ranks 78th in the industry for market value and 115th for net assets [3]
股票行情快报:天臣医疗(688013)11月14日主力资金净买入409.97万元